Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes

Medical Mycology

Volumn 43, Issue 1, 2005, Pages 61-66

  Esteban, A ^a   Abarca, M L ^a   Cabañes, F Javier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Agar diffusion; Broth microdilution; Dermatophytes; In vitro susceptibility testing; Neo Sensitabs

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; ITRACONAZOLE; TERBINAFINE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CLINICAL LABORATORY; DERMATOPHYTE; EPIDERMOPHYTON FLOCCOSUM; FUNGUS CULTURE; FUNGUS ISOLATION; INTERMETHOD COMPARISON; METHODOLOGY; MICROSPORUM CANIS; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAECILOMYCES; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CLOTRIMAZOLE; DRUG RESISTANCE, FUNGAL; EPIDERMOPHYTON; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; NAPHTHALENES; REAGENT KITS, DIAGNOSTIC; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANIS; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM; MICROSPORUM CANIS; TRICHOPHYTON; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 13244271343     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780410001711972     Document Type: Article

References (32)

1. Cabañes FJ. Dermatophytes in domestic animals. In: Kushwaha RKS, Guarro J (eds). Biology of Dermatophytes and Other Keratinophilic Fungi. Bilbao: Revista Iberoamericana de Micologia, 2000: 104-108.
2. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1: 247-261.
3. del Palacio A, Garau M, González-Escalada A, Calvo MT. Trends in the treatment of dermatophytosis. In: Kushwaha RKS, Guarro J (eds). Biology of Dermatophytes and Other Keratinophilic Fungi. Bilbao: Revista Iberoamericana de Micologia, 2000: 148-158.
4. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12: 40-79.
5. Mukherjee PK, Leidich SD, Isham N, et al. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003; 47: 82-86.
6. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-forming Filamentous Fungi. Proposed standard M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards, 1998.
7. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
8. Barchiesi F, Arzeni D, Camiletti V, et al. In vitro activity of Posaconazole against clinical isolates of dermatophytes. J Clin Microbiol 2001; 39: 4208-4209.
9. Fernández-Torres B, Carrillo AJ, Martín E, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001; 45: 2524-2528.
10. Fernández-Torres B, Vázquez-Veiga H, Llovo X, et al. In vitro susceptibility to Itraconazole, Clotrimazole, Ketoconazole and Terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy (Basel) 2000; 46: 390-394.
11. Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol 2000; 38: 155-159.
12. Favre B, Hofbauer B, Hildering K, Ryder NS. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J Clin Microbiol 2003; 41: 4817-4819.
13. Fernández-Torres B, Inza I, Guarro J. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J Clin Microbiol 2003; 41: 5209-5211.
14. Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz AJ, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
15. Anon. Neo-Sensitabs® Susceptibility Testing. User's guide Denmark: Rosco Diagnostica, 2002 (available at http://www.rosco.dk).
16. Cantón E, Pemán J, Carrillo-Muñoz A, et al. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards Method M27-A and two other methods. J Clin Microbiol 1999; 37: 2197-2200.
17. Carrillo-Muñoz AJ, Abarca L, Quindós G, et al. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing. Rev Iberoam Micol 1999; 16: 92-96.
18. Faiad Soni LM, Nascimento Burattini M, Campos Pignatari AC, et al. Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp. Mycopathologia 1999; 145: 131-135.
19. Quindós G, Abarca L, Carrillo- Muñoz AJ, et al. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients. Rev Iberoam Micol 1999; 16: 97-100.
20. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-1368.
21. Jessup CJ, Warner J, Isham N, et al. Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of clinical isolates. J Clin Microbiol 2000; 38: 341-344.
22. Oyeka CA, Gugnani HC. In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes. Mycopathologia 1990; 110: 157-161.
23. Hofbauer B, Leitner I, Ryder NS. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. Med Mycol 2002; 40: 179-183.
24. Fernández-Torres B, Carrillo-Muñoz A, Ortoneda M, et al. Interlaboratory evaluation of the Etest® for antifungal susceptibility testing of dermatophytes. Med Mycol 2003; 41: 125-130.
25. Perea S, Forthergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth microdilution method. J Clin Microbiol 2001; 39: 385-388.
26. Pujol I, Capilla J, Fernández-Torres B, et al. Use of the Sensititre Colorimetric Microdilution panel for antifungal susceptibility testing of dermatophytes. J Clin Microbiol 2002; 40: 2618-2621.
27. Espinel-Ingroff A, Dawson K, Waller M, et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995; 39: 314-319.
28. Cabañes FJ, Alonso JM, Castellá G, et al. Cutaneous Hyalohyphomycosis caused by Fusarium solani in a loggerhead sea turtle (Caretta caretta L.). J Clin Microbiol 1997; 35: 3343-3345.
29. Cabañes FJ, Abarca L, Bragulat MR, Bruguera T. Phaeohyphomycosis caused by Alternaria alternata in a mare. J Med Vet Mycol 1988; 26: 359-365.
30. Cabañes FJ, Roura X, García F, et al. Nasal granuloma caused by Scedosporium apiospermum in a dog. J Clin Microbiol 1998; 36: 2755-2758.
31. Cermeño-Vivas JR, Torres-Rodríguez JM. Sensibilidad de hongos miceliares dematiáceos a diez antifúngicos empleando un método de difusión en agar. Rev Iberoam Micol 2001; 18: 113-117.
32. Cabañes FJ, Abarca L, Bragulat MR, Bruguera T. Sensitivity of some strains of the genus Epidermophyton to different antifungal agents. Mycopathologia 1989; 105: 153-156.